The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ASH 2023 | Optimizing CNS prophylaxis in the treatment of ALL
Martin Schrappe, MD, University Medical Center Schleswig-Holstein, Kiel, Germany, explores optimal methods for CNS prophylaxis when treating acute lymphoblastic leukemia (ALL). Dr Schrappe highlights the importance of considering the subtype of ALL when choosing between cranial radiotherapy and intrathecal chemotherapy. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
